2023-03-17 06:58:02 ET
- Predictive Oncology's ( NASDAQ: POAI ) declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock for each outstanding common share held of record, as of March 27.
- The company said the outstanding shares of Series F Preferred Stock will vote together with the outstanding common stock, as a single class, exclusively with respect to a reverse stock split, and any proposal to adjourn any stockholders' meeting called for the purpose of voting on the reverse stock split, and will not be entitled to vote on any other matter, except if required under a law.
For further details see:
Predictive Oncology to distribute series F preferred stock to common stockholders